3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
257
Carcinoma, Intraductal, Noninfiltrating
24
Breast Carcinoma In Situ
21
Neoplasms
12
Neoplasm Metastasis
12
Breast Neoplasms, Male
12
Ovarian Neoplasms
10
Inflammatory Breast Neoplasms
7
Glioblastoma
6
Prostatic Neoplasms
5
Endometrial Neoplasms
5
Central Nervous System Neoplasms
5
Gliosarcoma
4
Fallopian Tube Neoplasms
4
Breast Cancer Female
4
Brain Neoplasms
4
Glioma
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Ductal, Breast
3
Breast Diseases
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Oligodendroglioma
2
Medulloblastoma
2
Liver Neoplasms
2
Infertility
2
Interventions
Tamoxifen
2
palbociclib
1
exemestane
1
elacestrant
1
Letrozole
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
ER+ Breast Cancer
×
Tamoxifen
×
Clear all
NCT04985266
2024-12-05
TRAK-ER
Royal Marsden NHS Foundation Trust
Phase 2
Recruiting
1,100 enrolled
NCT05525481
2023-11-01
PREDICTAM
Erasmus Medical Center
Phase 4
Unknown
100 enrolled